Sema4 Holdings Corp. (SMFR): Price and Financial Metrics

Sema4 Holdings Corp. (SMFR): $0.31

0.07 (+26.78%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

F

Add SMFR to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#327 of 382

in industry

SMFR Price/Volume Stats

Current price $0.31 52-week high $4.67
Prev. close $0.25 52-week low $0.22
Day low $0.25 Volume 4,716,400
Day high $0.33 Avg. volume 2,371,220
50-day MA $0.53 Dividend yield N/A
200-day MA $1.39 Market Cap 117.17M

SMFR Stock Price Chart Interactive Chart >


Sema4 Holdings Corp. (SMFR) Company Bio


Sema4 Holdings Corp., doing business as Sema4, develops and operates health intelligence software solution that helps in diagnosis, treatment, and prevention of disease. The company offers solutions, such as Sema4, a solution that helps in treatment of the diseases; Centrellis, an analytics platform that generate complete understanding of disease and wellness and extract individualized insights into human health, starting with reproductive health and oncology; Sema4 Signal, a solution that provides data driven care solutions with analytics, digital tools, and exome based somatic and hereditary cancer genomic test; Biopharma, a solution that offers portfolio of health information, pre-clinical and clinical trial support, analytics for actionable insights, and advance sequencing services. It offers noninvasive prenatal select, a blood test for determining baby's health; expanded carrier screen, a carrier screen for more than 280 inherited conditions if one is pregnant or planning for pregnancy; and CarrierCheck, a genetic screen for 67 inherited conditions to know how DNA could affect the children. The company also provides Natalis newborn screen, a home-test to know baby's health by screening for 193 childhood diseases; Solid Tumor panel to analyze cancer driven genes; and test catalogue, a comprehensive offering of genetic and genomic tests. In addition, it owns and operates Centrellis, an analytics platform that generate complete understanding of disease and wellness and extract individualized insights into human health, starting with reproductive health and oncology. The company's solutions include women's health, oncology, expanded carrier screen, noninvasive prenatal select, Natali's newborn screen, hereditary cancer. Sema4 Holdings Corp. is based in Stamford, Connecticut.


SMFR Latest News Stream


Event/Time News Detail
Loading, please wait...

SMFR Latest Social Stream


Loading social stream, please wait...

View Full SMFR Social Stream

SMFR Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -95.43%
5-year N/A
YTD N/A
2023 0.00%
2022 -94.09%
2021 -59.60%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!